CRL Annual CFF
-$85.52 M
-$43.12 M-101.71%
30 December 2023
Summary:
As of January 21, 2025, CRL annual cash flow from financing activities is -$85.52 million, with the most recent change of -$43.12 million (-101.71%) on December 30, 2023. During the last 3 years, it has fallen by -$132.77 million (-281.00%). CRL annual CFF is now -112.72% below its all-time high of $672.60 million, reached on December 25, 2021.CRL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly CFF
-$207.54 M
+$78.32 M+27.40%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly cash flow from financing activities is -$207.54 million, with the most recent change of +$78.32 million (+27.40%) on September 28, 2024. Over the past year, it has dropped by -$331.10 million (-267.95%). CRL quarterly CFF is now -128.84% below its all-time high of $719.51 million, reached on June 30, 2018.CRL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM CFF
-$351.48 M
-$44.67 M-14.56%
28 September 2024
Summary:
As of January 21, 2025, CRL TTM cash flow from financing activities is -$351.48 million, with the most recent change of -$44.67 million (-14.56%) on September 28, 2024. Over the past year, it has dropped by -$265.96 million (-310.99%). CRL TTM CFF is now -142.23% below its all-time high of $832.34 million, reached on September 25, 2021.CRL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -101.7% | -267.9% | -311.0% |
| 3 y3 years | -281.0% | -267.9% | -311.0% |
| 5 y5 years | -115.3% | -267.9% | -311.0% |
CRL Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -112.7% | at low | -176.5% | +27.4% | -152.3% | +23.3% |
| 5 y | 5-year | -112.7% | at low | -140.1% | +27.4% | -142.2% | +23.3% |
| alltime | all time | -112.7% | +68.5% | -128.8% | +27.4% | -142.2% | +23.3% |
Charles River Laboratories International Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$207.54 M(-27.4%) | -$351.48 M(+14.6%) |
| June 2024 | - | -$285.86 M(-1658.1%) | -$306.81 M(+232.0%) |
| Mar 2024 | - | $18.35 M(-85.2%) | -$92.42 M(+8.1%) |
| Dec 2023 | -$85.52 M(+101.7%) | $123.57 M(-175.9%) | -$85.52 M(-81.3%) |
| Sept 2023 | - | -$162.87 M(+127.9%) | -$458.05 M(+32.1%) |
| June 2023 | - | -$71.46 M(-383.1%) | -$346.77 M(+8853.6%) |
| Mar 2023 | - | $25.24 M(-110.1%) | -$3.87 M(-90.9%) |
| Dec 2022 | -$42.40 M(-106.3%) | -$248.96 M(+382.5%) | -$42.40 M(+241.6%) |
| Sept 2022 | - | -$51.59 M(-119.0%) | -$12.41 M(-105.7%) |
| June 2022 | - | $271.44 M(-2143.5%) | $218.08 M(-53.1%) |
| Mar 2022 | - | -$13.28 M(-93.9%) | $464.60 M(-30.9%) |
| Dec 2021 | $672.60 M(+1323.5%) | -$218.97 M(-222.4%) | $672.60 M(-19.2%) |
| Sept 2021 | - | $178.90 M(-65.5%) | $832.34 M(+116.3%) |
| June 2021 | - | $517.96 M(+166.0%) | $384.81 M(-262.2%) |
| Mar 2021 | - | $194.72 M(-428.8%) | -$237.24 M(-602.1%) |
| Dec 2020 | $47.25 M(-79.6%) | -$59.23 M(-78.0%) | $47.25 M(-29.9%) |
| Sept 2020 | - | -$268.64 M(+158.1%) | $67.43 M(-66.7%) |
| June 2020 | - | -$104.10 M(-121.7%) | $202.63 M(-74.0%) |
| Mar 2020 | - | $479.21 M(-1327.4%) | $780.23 M(+236.4%) |
| Dec 2019 | $231.94 M(-58.4%) | -$39.04 M(-70.7%) | $231.94 M(-14.6%) |
| Sept 2019 | - | -$133.44 M(-128.2%) | $271.54 M(+5.3%) |
| June 2019 | - | $473.51 M(-785.4%) | $257.91 M(-48.8%) |
| Mar 2019 | - | -$69.08 M(<-9900.0%) | $503.91 M(-9.7%) |
| Dec 2018 | $558.06 M(-367.7%) | $563.00 K(-100.4%) | $558.06 M(+10.6%) |
| Sept 2018 | - | -$147.08 M(-120.4%) | $504.49 M(-22.5%) |
| June 2018 | - | $719.51 M(-4917.3%) | $651.16 M(-536.8%) |
| Mar 2018 | - | -$14.94 M(-71.8%) | -$149.09 M(-28.5%) |
| Dec 2017 | -$208.48 M(-154.8%) | -$53.01 M(>+9900.0%) | -$208.48 M(+16.2%) |
| Sept 2017 | - | -$402.00 K(-99.5%) | -$179.39 M(-37.0%) |
| June 2017 | - | -$80.74 M(+8.6%) | -$284.56 M(-192.8%) |
| Mar 2017 | - | -$74.32 M(+210.6%) | $306.73 M(-19.4%) |
| Dec 2016 | $380.76 M(-5346.0%) | -$23.93 M(-77.3%) | $380.76 M(-6.9%) |
| Sept 2016 | - | -$105.57 M(-120.7%) | $408.86 M(-27.9%) |
| June 2016 | - | $510.54 M(<-9900.0%) | $566.72 M(-6074.3%) |
| Mar 2016 | - | -$294.00 K(-107.0%) | -$9.49 M(+30.7%) |
| Dec 2015 | -$7.26 M(-111.8%) | $4.18 M(-92.0%) | -$7.26 M(-227.8%) |
| Sept 2015 | - | $52.29 M(-179.6%) | $5.68 M(-107.1%) |
| June 2015 | - | -$65.66 M(-3495.1%) | -$80.53 M(-215.9%) |
| Mar 2015 | - | $1.93 M(-88.7%) | $69.49 M(+13.2%) |
| Dec 2014 | $61.41 M(-172.9%) | $17.12 M(-150.5%) | $61.41 M(+116.3%) |
| Sept 2014 | - | -$33.92 M(-140.2%) | $28.39 M(+21.4%) |
| June 2014 | - | $84.36 M(-1473.0%) | $23.39 M(-127.9%) |
| Mar 2014 | - | -$6.14 M(-61.4%) | -$83.87 M(-0.4%) |
| Dec 2013 | -$84.24 M(-24.2%) | -$15.91 M(-59.1%) | -$84.24 M(-2.6%) |
| Sept 2013 | - | -$38.91 M(+69.9%) | -$86.44 M(+15.2%) |
| June 2013 | - | -$22.91 M(+251.9%) | -$75.07 M(-13.7%) |
| Mar 2013 | - | -$6.51 M(-64.1%) | -$87.00 M(-21.7%) |
| Dec 2012 | -$111.12 M | -$18.11 M(-34.2%) | -$111.12 M(-25.4%) |
| Sept 2012 | - | -$27.54 M(-21.0%) | -$149.02 M(-34.5%) |
| June 2012 | - | -$34.84 M(+13.7%) | -$227.62 M(-16.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$30.64 M(-45.3%) | -$273.37 M(+0.6%) |
| Dec 2011 | -$271.79 M(+61.9%) | -$56.01 M(-47.2%) | -$271.79 M(+18.1%) |
| Sept 2011 | - | -$106.14 M(+31.7%) | -$230.13 M(+7.4%) |
| June 2011 | - | -$80.59 M(+177.4%) | -$214.33 M(+23.4%) |
| Mar 2011 | - | -$29.05 M(+102.4%) | -$173.71 M(+3.5%) |
| Dec 2010 | -$167.90 M(+107.3%) | -$14.36 M(-84.1%) | -$167.90 M(+3.7%) |
| Sept 2010 | - | -$90.34 M(+126.0%) | -$161.84 M(+62.2%) |
| June 2010 | - | -$39.97 M(+72.0%) | -$99.75 M(+51.2%) |
| Mar 2010 | - | -$23.24 M(+179.8%) | -$65.99 M(-18.5%) |
| Dec 2009 | -$80.98 M(+367.5%) | -$8.30 M(-70.6%) | -$80.98 M(+26.9%) |
| Sept 2009 | - | -$28.24 M(+355.4%) | -$63.81 M(+82.5%) |
| June 2009 | - | -$6.20 M(-83.8%) | -$34.97 M(-15.6%) |
| Mar 2009 | - | -$38.23 M(-531.2%) | -$41.44 M(+139.3%) |
| Dec 2008 | -$17.32 M(-62.7%) | $8.87 M(+1377.5%) | -$17.32 M(-44.9%) |
| Sept 2008 | - | $600.00 K(-104.7%) | -$31.44 M(-45.9%) |
| June 2008 | - | -$12.68 M(-10.1%) | -$58.10 M(+42.6%) |
| Mar 2008 | - | -$14.11 M(+168.5%) | -$40.73 M(-12.3%) |
| Dec 2007 | -$46.43 M(-962.0%) | -$5.25 M(-79.8%) | -$46.43 M(-31.9%) |
| Sept 2007 | - | -$26.06 M(-655.6%) | -$68.16 M(-44.9%) |
| June 2007 | - | $4.69 M(-123.7%) | -$123.66 M(+368.2%) |
| Mar 2007 | - | -$19.80 M(-26.6%) | -$26.41 M(-590.3%) |
| Dec 2006 | $5.39 M(-102.8%) | -$26.98 M(-66.9%) | $5.39 M(-108.9%) |
| Sept 2006 | - | -$81.56 M(-180.0%) | -$60.75 M(+3320.5%) |
| June 2006 | - | $101.94 M(+749.9%) | -$1.78 M(-99.0%) |
| Mar 2006 | - | $11.99 M(-112.9%) | -$173.81 M(-11.1%) |
| Dec 2005 | -$195.42 M(-144.7%) | -$93.12 M(+312.2%) | -$195.42 M(-159.9%) |
| Sept 2005 | - | -$22.59 M(-67.8%) | $326.52 M(-7.0%) |
| June 2005 | - | -$70.10 M(+629.2%) | $351.12 M(-17.0%) |
| Mar 2005 | - | -$9.61 M(-102.2%) | $422.98 M(-3.2%) |
| Dec 2004 | $436.95 M(-5069.8%) | $428.82 M(>+9900.0%) | $436.95 M(<-9900.0%) |
| Sept 2004 | - | $2.01 M(+14.5%) | -$2.14 M(-275.3%) |
| June 2004 | - | $1.76 M(-59.6%) | $1.22 M(-152.2%) |
| Mar 2004 | - | $4.36 M(-142.4%) | -$2.34 M(-73.4%) |
| Dec 2003 | -$8.79 M(-269.9%) | -$10.27 M(-291.0%) | -$8.79 M(+4188.8%) |
| Sept 2003 | - | $5.38 M(-398.1%) | -$205.00 K(-93.4%) |
| June 2003 | - | -$1.80 M(-14.0%) | -$3.09 M(-95.7%) |
| Mar 2003 | - | -$2.10 M(+24.8%) | -$72.17 M(-1494.7%) |
| Dec 2002 | $5.17 M(-89.0%) | -$1.68 M(-167.4%) | $5.17 M(-116.2%) |
| Sept 2002 | - | $2.49 M(-103.5%) | -$31.92 M(-423.7%) |
| June 2002 | - | -$70.89 M(-194.2%) | $9.86 M(-70.8%) |
| Mar 2002 | - | $75.25 M(-294.1%) | $33.82 M(-28.4%) |
| Dec 2001 | $47.23 M(+5939.6%) | -$38.77 M(-187.6%) | $47.23 M(-44.6%) |
| Sept 2001 | - | $44.27 M(-194.3%) | $85.29 M(+111.5%) |
| June 2001 | - | -$46.93 M(-152.9%) | $40.33 M(-53.0%) |
| Mar 2001 | - | $88.66 M(<-9900.0%) | $85.72 M(>+9900.0%) |
| Dec 2000 | $782.00 K(-106.8%) | -$711.00 K(+2.9%) | $782.00 K(-47.6%) |
| Sept 2000 | - | -$691.00 K(-55.0%) | $1.49 M(-31.6%) |
| June 2000 | - | -$1.54 M(-141.3%) | $2.18 M(-41.3%) |
| Mar 2000 | - | $3.72 M | $3.72 M |
| Dec 1999 | -$11.50 M(+43.5%) | - | - |
| Dec 1998 | -$8.02 M | - | - |
FAQ
- What is Charles River Laboratories International annual cash flow from financing activities?
- What is the all time high annual CFF for Charles River Laboratories International?
- What is Charles River Laboratories International annual CFF year-on-year change?
- What is Charles River Laboratories International quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly CFF year-on-year change?
- What is Charles River Laboratories International TTM cash flow from financing activities?
- What is the all time high TTM CFF for Charles River Laboratories International?
- What is Charles River Laboratories International TTM CFF year-on-year change?
What is Charles River Laboratories International annual cash flow from financing activities?
The current annual CFF of CRL is -$85.52 M
What is the all time high annual CFF for Charles River Laboratories International?
Charles River Laboratories International all-time high annual cash flow from financing activities is $672.60 M
What is Charles River Laboratories International annual CFF year-on-year change?
Over the past year, CRL annual cash flow from financing activities has changed by -$43.12 M (-101.71%)
What is Charles River Laboratories International quarterly cash flow from financing activities?
The current quarterly CFF of CRL is -$207.54 M
What is the all time high quarterly CFF for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly cash flow from financing activities is $719.51 M
What is Charles River Laboratories International quarterly CFF year-on-year change?
Over the past year, CRL quarterly cash flow from financing activities has changed by -$331.10 M (-267.95%)
What is Charles River Laboratories International TTM cash flow from financing activities?
The current TTM CFF of CRL is -$351.48 M
What is the all time high TTM CFF for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM cash flow from financing activities is $832.34 M
What is Charles River Laboratories International TTM CFF year-on-year change?
Over the past year, CRL TTM cash flow from financing activities has changed by -$265.96 M (-310.99%)